Search

Author/Creator Simionato, F.

2. HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research. Issue 12 (16th September 2016)

Authors:
Pietrantonio, F.; Caporale, M.; Morano, F.; Scartozzi, M.; Gloghini, A.; De Vita, F.; Giommoni, E.; Fornaro, L.; Aprile, G.; Melisi, D.; Berenato, R.; Mennitto, A.; Volpi, C. C.; Laterza, M. M.; Pusceddu, V.; Antonuzzo, L.; Vasile, E.; Ongaro, E.; Simionato, F.; de Braud, F.
Journal:
International journal of cancer
Issue:
Volume 139:Issue 12(2016:Dec. 15)
Page Start:
2859
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement. (March 2023)

Authors:
Catanzaro, E.; Peviani, M.; Perin, N.; Bonaiuto, E.; Simionato, F.; Motta, R.; Gambato, M.; Floreani, A.; Cazzagon, N.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Quality of life outcomes in people with Primary Biliary Cholangitis treated with obeticholic acid: results of a phase 4 real life observational trial. (March 2023)

Authors:
Rollo, P.; D'Ovidio, E.; Bonaiuto, E.; Perini, L.; Pezzato, F.; Peviani, M.; Simionato, F.; Russo, F.P.; Floreani, A.; Cazzagon, N.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗